Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 740

1.

Ten-year follow-up study of linear immunoglobulin A dermatosis complicated with ulcerative colitis.

Sonoyama H, Mishima Y, Ishihara S, Oshima N, Moriyama I, Kawashima K, Chinuki Y, Morita E, Kinoshita Y.

Clin J Gastroenterol. 2019 Sep 25. doi: 10.1007/s12328-019-01047-w. [Epub ahead of print]

PMID:
31555959
2.

Phosphoinositide 3-Kinase P110δ-Signaling Is Critical for Microbiota-Activated IL-10 Production by B Cells that Regulate Intestinal Inflammation.

Oka A, Mishima Y, Liu B, Herzog JW, Steinbach EC, Kobayashi T, Plevy SE, Sartor RB.

Cells. 2019 Sep 21;8(10). pii: E1121. doi: 10.3390/cells8101121.

3.

Deletion of Gb3 Synthase in Mice Resulted in the Attenuation of Bone Formation via Decrease in Osteoblasts.

Hamamura K, Hamajima K, Yo S, Mishima Y, Furukawa K, Uchikawa M, Kondo Y, Mori H, Kondo H, Tanaka K, Miyazawa K, Goto S, Togari A.

Int J Mol Sci. 2019 Sep 18;20(18). pii: E4619. doi: 10.3390/ijms20184619.

4.

Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.

Mishima Y, Sartor RB.

J Gastroenterol. 2019 Sep 3. doi: 10.1007/s00535-019-01618-1. [Epub ahead of print] Review.

PMID:
31482438
5.

Clinical Features of Febrile Urinary Tract Infection Caused by Extended-spectrum Beta-lactamase-producing Escherichia Coli in Children.

Ohnishi T, Mishima Y, Takizawa S, Tsutsumi K, Amemiya A, Akiyama N, Kanna Y, Asato S, Tomita M, Ikemiyagi M, Shikoro N, Nakazawa M, Kurihara N, Kamimaki I.

Keio J Med. 2019 Aug 30. doi: 10.2302/kjm.2019-0005-OA. [Epub ahead of print]

6.

Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.

Ghobrial IM, Liu CJ, Zavidij O, Azab AK, Baz R, Laubach JP, Mishima Y, Armand P, Munshi NC, Basile F, Constantine M, Vredenburgh J, Boruchov A, Crilley P, Henrick PM, Hornburg KTV, Leblebjian H, Chuma S, Reyes K, Noonan K, Warren D, Schlossman R, Paba-Prada C, Anderson KC, Weller E, Trippa L, Shain K, Richardson PG.

Am J Hematol. 2019 Nov;94(11):1244-1253. doi: 10.1002/ajh.25627. Epub 2019 Oct 4.

PMID:
31456261
7.

Pulsed call sequences as contact calls in Pacific white-sided dolphins (Lagenorhynchus obliquidens).

Mishima Y, Morisaka T, Ishikawa M, Karasawa Y, Yoshida Y.

J Acoust Soc Am. 2019 Jul;146(1):409. doi: 10.1121/1.5116692.

PMID:
31370601
8.

Chemical synthesis of the ubiquitinated form of histone H3 and its effect on DNA methyltransferase 1.

Kawakami T, Mishima Y, Takazawa M, Hojo H, Suetake I.

J Pept Sci. 2019 Sep;25(9):e3200. doi: 10.1002/psc.3200. Epub 2019 Jul 15.

PMID:
31309659
9.

[Role of mucosal inflammation in irritable bowel syndrome].

Mishima Y, Ishihara S.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(7):560-569. doi: 10.11405/nisshoshi.116.560. Japanese. No abstract available.

PMID:
31292317
10.

Thermal Decomposition Behavior of a Chelating Resin Immobilizing Carboxymethylated Polyethyleneimine: Possibility of Estimation of Carboxymethylation Rate.

Kagaya S, Mishima Y, Obata I, Gemmei-Ide M, Inoue Y, Tsugoshi T.

Anal Sci. 2019 Oct 10;35(10):1161-1164. doi: 10.2116/analsci.19N017. Epub 2019 Jun 28.

11.

Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells.

Mishima Y, Oka A, Liu B, Herzog JW, Eun CS, Fan TJ, Bulik-Sullivan E, Carroll IM, Hansen JJ, Chen L, Wilson JE, Fisher NC, Ting JP, Nochi T, Wahl A, Garcia JV, Karp CL, Sartor RB.

J Clin Invest. 2019 Jun 18;130:3702-3716. doi: 10.1172/JCI93820.

12.

Deficiency of GD3 Synthase in Mice Resulting in the Attenuation of Bone Loss with Aging.

Yo S, Hamamura K, Mishima Y, Hamajima K, Mori H, Furukawa K, Kondo H, Tanaka K, Sato T, Miyazawa K, Goto S, Togari A.

Int J Mol Sci. 2019 Jun 10;20(11). pii: E2825. doi: 10.3390/ijms20112825.

13.

Capabilities of fecal calprotectin and blood biomarkers as surrogate endoscopic markers according to ulcerative colitis disease type.

Sonoyama H, Kawashima K, Ishihara S, Kotani S, Fukuba N, Oka A, Kusunoki R, Tada Y, Mishima Y, Oshima N, Moriyama I, Yuki T, Onishi K, Kinoshita Y.

J Clin Biochem Nutr. 2019 May;64(3):265-270. doi: 10.3164/jcbn.18-92. Epub 2019 Mar 7.

14.

Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2).

Yokoyama M, Kusano Y, Nishihara A, Inoue N, Nishimura N, Mishima Y, Terui Y, Nukada T, Nomura T, Hatake K.

Support Care Cancer. 2019 May 15. doi: 10.1007/s00520-019-04802-4. [Epub ahead of print]

PMID:
31093770
15.

Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma.

Sahin I, Kawano Y, Sklavenitis-Pistofidis R, Moschetta M, Mishima Y, Manier S, Sacco A, Carrasco R, Fonseca R, Roccaro AM, Witzig T, Ghobrial IM.

Blood Adv. 2019 Apr 9;3(7):995-1002. doi: 10.1182/bloodadvances.2018028456.

16.

Irritable Bowel Syndrome-Like Symptoms in Ulcerative Colitis Patients in Clinical Remission: Association with Residual Colonic Inflammation.

Ishihara S, Kawashima K, Fukuba N, Tada Y, Kotani S, Mishima Y, Oshima N, Kinoshita Y.

Digestion. 2019;99(1):46-51. doi: 10.1159/000494412. Epub 2018 Dec 14. Review.

17.

Treatment of asthma in smokers: A questionnaire survey in Japanese clinical practice.

Saito H, Tsuchiya K, Chiba S, Ogata T, Imase R, Yagi T, Mishima Y, Jinta T, Saito K, Taki R, Isogai S, Jin Y, Kawasaki T, Natsume I, Miyashita Y, Takagiwa J, Ishiwata N, Chiaki T, Kishi M, Tsukada Y, Yamasaki M, Inase N, Miyazaki Y.

Respir Investig. 2019 Mar;57(2):126-132. doi: 10.1016/j.resinv.2018.11.001. Epub 2018 Dec 11.

PMID:
30552072
18.

Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma.

Mishima Y, Fukaishi T, Inase N, Isogai S.

Intern Med. 2019 Mar 1;58(5):693-697. doi: 10.2169/internalmedicine.1268-18. Epub 2018 Nov 19.

19.

Environmental Factors Modify the Severity of Acute DSS Colitis in Caspase-11-Deficient Mice.

Fan TJ, Tchaptchet SY, Arsene D, Mishima Y, Liu B, Sartor RB, Carroll IM, Miao EA, Fodor AA, Hansen JJ.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2394-2403. doi: 10.1093/ibd/izy244.

20.

Deadenylation by the CCR4-NOT complex contributes to the turnover of hairy-related mRNAs in the zebrafish segmentation clock.

Fujino Y, Yamada K, Sugaya C, Ooka Y, Ovara H, Ban H, Akama K, Otosaka S, Kinoshita H, Yamasu K, Mishima Y, Kawamura A.

FEBS Lett. 2018 Oct;592(20):3388-3398. doi: 10.1002/1873-3468.13261. Epub 2018 Oct 15.

21.

Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate.

Mishima Y, Kurano M, Kobayashi T, Nishikawa M, Ohkawa R, Tozuka M, Yatomi Y.

Biosci Rep. 2018 Oct 31;38(5). pii: BSR20181288. doi: 10.1042/BSR20181288. Print 2018 Oct 31.

22.

A peptide inhibitor of antibody-dependent cell-mediated cytotoxicity against EGFR/folate receptor-α double positive cells.

Sasaki K, Miyashita Y, Asai D, Funamoto D, Sato K, Yamaguchi Y, Mishima Y, Iino T, Takaishi S, Nagano J, Kishimura A, Mori T, Katayama Y.

Medchemcomm. 2018 Feb 26;9(5):783-788. doi: 10.1039/c8md00010g. eCollection 2018 May 1.

23.

Chitin promotes antigen-specific Th2 cell-mediated murine asthma through induction of IL-33-mediated IL-1β production by DCs.

Arae K, Morita H, Unno H, Motomura K, Toyama S, Okada N, Ohno T, Tamari M, Orimo K, Mishima Y, Suto H, Okumura K, Sudo K, Miyazawa H, Taguchi H, Saito H, Matsumoto K, Nakae S.

Sci Rep. 2018 Aug 6;8(1):11721. doi: 10.1038/s41598-018-30259-2.

24.

PAINTing translation.

Mishima Y.

Nat Chem Biol. 2018 Sep;14(9):832-833. doi: 10.1038/s41589-018-0102-8. No abstract available.

PMID:
29988066
25.

Apnea and delirious behavior caused by mild encephalitis/encephalopathy with reversible splenial lesion complicated with rotavirus infection.

Ohnishi T, Mishima Y, Shinozuka S, Shikoro N, Kamimaki I.

Pediatr Int. 2018 Jun;60(6):602-604. doi: 10.1111/ped.13582. No abstract available.

PMID:
29924480
26.

Effects of Helicobacter pylori eradication on serum lipid levels.

Adachi K, Mishiro T, Toda T, Kano N, Fujihara H, Mishima Y, Konishi A, Mochida M, Takahashi K, Kinoshita Y.

J Clin Biochem Nutr. 2018 May;62(3):264-269. doi: 10.3164/jcbn.17-88. Epub 2018 Jan 27.

27.

Interactions of HP1 Bound to H3K9me3 Dinucleosome by Molecular Simulations and Biochemical Assays.

Watanabe S, Mishima Y, Shimizu M, Suetake I, Takada S.

Biophys J. 2018 May 22;114(10):2336-2351. doi: 10.1016/j.bpj.2018.03.025. Epub 2018 Apr 21.

28.

Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab.

Kurdi AT, Glavey SV, Bezman NA, Jhatakia A, Guerriero JL, Manier S, Moschetta M, Mishima Y, Roccaro A, Detappe A, Liu CJ, Sacco A, Huynh D, Tai YT, Robbins MD, Azzi J, Ghobrial IM.

Mol Cancer Ther. 2018 Jul;17(7):1454-1463. doi: 10.1158/1535-7163.MCT-17-0998. Epub 2018 Apr 13.

29.

Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.

Kawano Y, Zavidij O, Park J, Moschetta M, Kokubun K, Mouhieddine TH, Manier S, Mishima Y, Murakami N, Bustoros M, Pistofidis RS, Reidy M, Shen YJ, Rahmat M, Lukyanchykov P, Karreci ES, Tsukamoto S, Shi J, Takagi S, Huynh D, Sacco A, Tai YT, Chesi M, Bergsagel PL, Roccaro AM, Azzi J, Ghobrial IM.

J Clin Invest. 2018 Jun 1;128(6):2487-2499. doi: 10.1172/JCI88169. Epub 2018 May 14.

30.

Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation.

Takagi S, Tsukamoto S, Park J, Johnson KE, Kawano Y, Moschetta M, Liu CJ, Mishima Y, Kokubun K, Manier S, Salem KZ, Huynh D, Sacco A, Forward J, Roccaro AM, Battinelli EM, Ghobrial IM.

Clin Cancer Res. 2018 May 15;24(10):2430-2439. doi: 10.1158/1078-0432.CCR-17-2003. Epub 2018 Feb 9.

31.

Serum amyloid A level correlated with endoscopic findings in patients with Crohn's disease-Possible biomarker for evaluating mucosal healing.

Ishihara S, Tada Y, Kawashima K, Kataoka M, Sonoyama H, Yamashita N, Oka A, Kusunoki R, Fukuba N, Mishima Y, Oshima N, Moriyama I, Yuki T, Kinoshita Y.

Dig Liver Dis. 2018 Jun;50(6):553-558. doi: 10.1016/j.dld.2017.12.010. Epub 2017 Dec 19.

PMID:
29311027
32.

Irritable bowel syndrome-like symptoms associated with endoscopic activity predict ulcerative colitis relapse in patients with clinical remission.

Fukuba N, Ishihara S, Kawashima K, Mishima Y, Oshima N, Kinoshita Y.

Intest Res. 2017 Oct;15(4):543-545. doi: 10.5217/ir.2017.15.4.543. Epub 2017 Oct 23. No abstract available.

33.

Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance.

Kusano Y, Yokoyama M, Inoue N, Yamauchi H, Takahashi A, Tsuyama N, Mishima Y, Nishimura N, Takeuchi K, Terui Y, Hatake K.

Ann Hematol. 2018 Feb;97(2):289-297. doi: 10.1007/s00277-017-3175-7. Epub 2017 Nov 14.

PMID:
29138885
34.

Bearing 19q13 aberration predicts poor prognosis in non-germinal centre type of CD5+ DLBCL.

Mishima Y, Terui Y, Yokoyama M, Nishimura N, Ueda K, Kusano Y, Yamauchi H, Inoue N, Takahashi A, Tsuyama N, Mishima Y, Takeuchi K, Hatake K.

Br J Haematol. 2018 Nov;183(4):661-664. doi: 10.1111/bjh.15001. Epub 2017 Oct 26. No abstract available.

PMID:
29076146
35.

Structure of the Dnmt1 Reader Module Complexed with a Unique Two-Mono-Ubiquitin Mark on Histone H3 Reveals the Basis for DNA Methylation Maintenance.

Ishiyama S, Nishiyama A, Saeki Y, Moritsugu K, Morimoto D, Yamaguchi L, Arai N, Matsumura R, Kawakami T, Mishima Y, Hojo H, Shimamura S, Ishikawa F, Tajima S, Tanaka K, Ariyoshi M, Shirakawa M, Ikeguchi M, Kidera A, Suetake I, Arita K, Nakanishi M.

Mol Cell. 2017 Oct 19;68(2):350-360.e7. doi: 10.1016/j.molcel.2017.09.037.

36.

High pretreatment level of soluble interleukin-2 receptor is a robust prognostic factor in patients with follicular lymphoma treated with R-CHOP-like therapy.

Kusano Y, Yokoyama M, Terui Y, Inoue N, Takahashi A, Yamauchi H, Tsuyama N, Nishimura N, Mishima Y, Takeuchi K, Hatake K.

Blood Cancer J. 2017 Sep 29;7(9):e614. doi: 10.1038/bcj.2017.96. No abstract available.

37.

Prevention of Mandible Reconstruction Plate Exposure by Costal Cartilage Wrapping.

Iwasawa M, Mishima Y, Ohtsubo M.

Plast Reconstr Surg Glob Open. 2017 Aug 4;5(8):e1438. doi: 10.1097/GOX.0000000000001438. eCollection 2017 Aug.

38.

A case of biliary atresia with pancreaticobiliary maljunction.

Endo K, Yokoi A, Mishima Y, Tamaki A, Morita K, Okata Y, Hisamatsu C, Fukuzawa H, Yoshida M, Akasaka Y, Maeda K.

Surg Case Rep. 2017 Sep 5;3(1):100. doi: 10.1186/s40792-017-0375-2.

39.

RFTS-dependent negative regulation of Dnmt1 by nucleosome structure and histone tails.

Mishima Y, Brueckner L, Takahashi S, Kawakami T, Arita K, Oka S, Otani J, Hojo H, Shirakawa M, Shinohara A, Watanabe M, Suetake I.

FEBS J. 2017 Oct;284(20):3455-3469. doi: 10.1111/febs.14205. Epub 2017 Sep 11.

40.

Fecal Calprotectin More Accurately Predicts Endoscopic Remission of Crohn's Disease than Serological Biomarkers Evaluated Using Balloon-assisted Enteroscopy.

Kawashima K, Ishihara S, Yuki T, Fukuba N, Sonoyama H, Kazumori H, Yamashita N, Tada Y, Kusunoki R, Oka A, Oshima N, Mishima Y, Moriyama I, Kinoshita Y.

Inflamm Bowel Dis. 2017 Nov;23(11):2027-2034. doi: 10.1097/MIB.0000000000001202.

PMID:
28817462
41.

Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.

Tsuyama N, Asaka R, Dobashi A, Baba S, Mishima Y, Ueda K, Oguchi M, Tsuji H, Hatake K, Takeuchi K.

Hematol Oncol. 2018 Feb;36(1):328-335. doi: 10.1002/hon.2459. Epub 2017 Jul 10.

PMID:
28695659
42.

Efficacy of chemotherapy in extremely elderly patients with diffuse large B-cell lymphoma.

Takahashi A, Mishima Y, Yokoyama M, Inoue N, Kusano Y, Gunji T, Nitta H, Ueda K, Nishimura N, Tsuyama N, Takeuchi K, Terui Y, Hatake K.

Rinsho Ketsueki. 2017;58(5):427-432. doi: 10.11406/rinketsu.58.427. Japanese.

PMID:
28592754
43.

Ecological dissimilarity among land-use/land-cover types improves a heterogeneity index for predicting biodiversity in agricultural landscapes.

Yoshioka A, Fukasawa K, Mishima Y, Sasaki K, Kadoya T.

Ambio. 2017 Dec;46(8):894-906. doi: 10.1007/s13280-017-0925-7. Epub 2017 Jun 1.

44.

Pervasive yet nonuniform contributions of Dcp2 and Cnot7 to maternal mRNA clearance in zebrafish.

Mishima Y, Tomari Y.

Genes Cells. 2017 Jul;22(7):670-678. doi: 10.1111/gtc.12504. Epub 2017 May 30.

45.

Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan.

Yokoyama M, Kusano Y, Takahashi A, Inoue N, Ueda K, Nishimura N, Mishima Y, Terui Y, Nukada T, Nomura T, Hatake K.

Support Care Cancer. 2017 Nov;25(11):3313-3320. doi: 10.1007/s00520-017-3747-z. Epub 2017 May 27.

46.

BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.

Tsuyama N, Sakata S, Baba S, Mishima Y, Nishimura N, Ueda K, Yokoyama M, Terui Y, Hatake K, Kitagawa M, Ishizuka N, Tomita N, Takeuchi K.

Blood. 2017 Jul 27;130(4):489-500. doi: 10.1182/blood-2016-12-759621. Epub 2017 May 18.

PMID:
28522442
47.

Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients.

Mishima Y, Matsusaka S, Chin K, Mikuniya M, Minowa S, Takayama T, Shibata H, Kuniyoshi R, Ogura M, Terui Y, Mizunuma N, Hatake K.

Target Oncol. 2017 Jun;12(3):341-351. doi: 10.1007/s11523-017-0493-6.

PMID:
28508152
48.

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.

Kusano Y, Yokoyama M, Terui Y, Nishimura N, Mishima Y, Ueda K, Tsuyama N, Yamauchi H, Takahashi A, Inoue N, Takeuchi K, Hatake K.

Blood Cancer J. 2017 May 12;7(5):e561. doi: 10.1038/bcj.2017.43. No abstract available.

49.

A novel in vivo model for studying conditional dual loss of BLIMP-1 and p53 in B-cells, leading to tumor transformation.

Sacco A, Kawano Y, Moschetta M, Zavidij O, Huynh D, Reagan M, Mishima Y, Manier S, Park J, Morgan E, Takagi S, Wong KK, Carrasco R, Ghobrial IM, Roccaro AM.

Am J Hematol. 2017 Aug;92(8):E138-E145. doi: 10.1002/ajh.24778. Epub 2017 Jun 15.

50.

Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma.

Kusano Y, Yokoyama M, Terui Y, Nishimura N, Mishima Y, Ueda K, Tsuyama N, Yamauchi H, Takahashi A, Inoue N, Takeuchi K, Hatake K.

Blood Cancer J. 2017 Apr 21;7(4):e558. doi: 10.1038/bcj.2017.37. Erratum in: Blood Cancer J. 2017 May 12;7(5):e561.

Supplemental Content

Loading ...
Support Center